NC
DARE icon

Nexthera Capital’s Dare Bioscience DARE Stock Holding History

Nexthera Capital’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-417
Closed -$140K – 34
2015
Q4 		$140K Buy
+417
New +$173K 0.2% 42

Other funds holding DARE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Nexthera Capital's DARE Position: Q1 2016 in Review

Nexthera Capital sold out of Dare Bioscience (DARE) in Q1 2016, closing a stake of 417 shares — an estimated $140K sold.

Nexthera Capital first reported a position in DARE in Q4 2015 and held it in 1 quarter. The position peaked at $140K in Q4 2015. 37 funds tracked by Wall St. Rank hold DARE as of Q1 2016.

  • Nexthera Capital reported no remaining Dare Bioscience position as of Q1 2016 after selling out during the quarter.
  • Nexthera Capital sold 417 Dare Bioscience shares in Q1 2016, an estimated $140K.
  • Nexthera Capital first reported a position in Dare Bioscience in Q4 2015 and held it in 1 quarter.
  • Nexthera Capital's Dare Bioscience position peaked at $140K in Q4 2015.
  • 37 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2016.

Based on Nexthera Capital's 13F filing for Q1 2016, filed 13 May 2016.